Poltreg S.A. (WSE:PTG)

Market Cap	132.44M
Revenue (ttm)	250.00K
Net Income (ttm)	-24.38M
Shares Out	4.66M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,122
Average Volume	6,079
Open	27.50
Previous Close	27.50
Day's Range	26.50 - 28.50
52-Week Range	22.70 - 55.20
Beta	0.89
RSI	46.70
Earnings Date	Sep 3, 2025

About Poltreg

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Employees: 33
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: PTG

Financial Performance

In 2024, Poltreg's revenue was 350,000, a decrease of -74.98% compared to the previous year's 1.40 million. Losses were -18.71 million, 38.1% more than in 2023.